| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
4105
|
77.80 | 19.3B | 2.79 | 2.78 | 2.24 | 24.5% | 10.1% | 90 | 84 | 183.64 | +102.0% | 86 | 0.30 |
|
1795
|
186.00 | 49.5B | 3.29 | 2.04 | 2.76 | 7.3% | 6.5% | 79 | 66 | 418.75 | +93.8% | 53 | 2.40 |
|
4123
|
31.25 | 24.8B | 6.08 | 1.44 | 28.37 | 0.3% | 9.8% | 75 | 50 | 54.34 | +53.2% | 68 | 0.24 |
|
4728
|
402.00 | 21.9B | 7.56 | 18.46 | 4.90 | 834.7% | 10.9% | 75 | 80 | 432.68 | +5.7% | 93 | 0.10 |
|
6472
|
470.00 | 59.8B | 8.22 | 3.95 | 4.60 | 8.5% | 8.7% | 67 | 63 | 641.54 | +27.4% | 61 | 1.44 |
|
6696
|
95.70 | 79.4B | — | 0.75 | — | -3.5% | 9.9% | 58 | 35 | 287.10 | +96.0% | 100 | 0.00 |
|
6535
|
77.50 | 12.9B | — | 10.40 | — | -39.9% | 12.4% | 28 | 19 | 19.74 | -35.8% | 67 | 0.00 |
|
6919
|
94.80 | 147.5B | — | 16.02 | — | -12.6% | 9.9% | 26 | 13 | 23.70 | -36.0% | 66 | 0.01 |
|
6949
|
1,490.00 | 97.7B | — | 37.96 | — | -62.6% | 9.9% | 20 | 3 | 372.50 | -36.0% | 65 | 0.09 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.